Department of Ophthalmology, EyeSight Foundation of Alabama Vision Science Laboratories Room 360, University of Alabama School of Medicine, Birmingham, AL 35294-0019, USA.
Br J Ophthalmol. 2011 Dec;95(12):1638-45. doi: 10.1136/bjophthalmol-2011-300344. Epub 2011 Sep 2.
Ageing is the largest risk factor for age-related macular degeneration (AMD), and soft drusen and basal linear deposits are lipid-rich extracellular lesions specific to AMD. Oil red O binding neutral lipid represents a major age-related deposition in the Bruch membrane (BrM) and the first identified druse component. Decades after these seminal observations, a natural history of neutral lipid deposition has been articulated and a biochemical model proposed. Results obtained with multiple biochemical, histochemical, and ultrastructural methods, and supported indirectly by epidemiology, suggest that the RPE secretes apolipoprotein B (apoB)-lipoprotein particles of unusual composition into BrM, where they accumulate with age eventually forming a lipid wall, a precursor of basal linear deposit. The authors propose that constituents of these lesions interact with reactive oxygen species to form pro-inflammatory peroxidised lipids that elicit neovascularisation. Here, the authors summarise key evidence supporting both accumulation of BrM lipoproteins leading to lesion formation and lipoprotein production by the RPE. The authors update their model with genetic associations between AMD and genes historically associated with plasma HDL metabolism, and suggest future directions for research and therapeutic strategies based on an oil-spill analogy.
衰老是年龄相关性黄斑变性 (AMD) 的最大风险因素,软玻璃疣和基底线性沉积是特定于 AMD 的富含脂质的细胞外病变。油红 O 结合中性脂质代表了 Bruch 膜 (BrM) 中与年龄相关的主要沉积,也是首次鉴定的玻璃疣成分。在这些开创性观察之后的几十年里,已经阐明了中性脂质沉积的自然史,并提出了生化模型。通过多种生化、组织化学和超微结构方法获得的结果,并通过流行病学间接支持,表明 RPE 将具有异常组成的载脂蛋白 B (apoB)-脂蛋白颗粒分泌到 BrM 中,随着年龄的增长,它们在 BrM 中积累,最终形成脂质壁,这是基底线性沉积的前体。作者提出,这些病变的成分与活性氧相互作用,形成引发新生血管形成的促炎过氧化物脂质。在这里,作者总结了支持 BrM 脂蛋白积累导致病变形成和 RPE 产生脂蛋白的关键证据。作者根据 AMD 与历史上与血浆高密度脂蛋白代谢相关的基因之间的遗传关联,更新了他们的模型,并根据溢油类比提出了未来的研究和治疗策略方向。